Prellis Biologics, Inc. Generates 300 Human Antibodies That Bind the SARS-CoV2 Virus; Pursues Development of a Treatment and Preventative Therapy for COVID-19 Infection

HAYWARD, Calif.--(BUSINESS WIRE)-- #3Dbioprinting--Prellis has generated 300 human antibodies for treatment and prevention of COVID-19; reduces time to produce candidate antibodies to under a month.

Click to view original post